State AL
Clinical Trials in Alabama
Alabama is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Alabama and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 158 actively recruiting studies with Alabama sites out of 158 registered in total. The busiest research areas in Alabama are Obesity, Ovarian Cancer, Prostate Cancer. Leading sponsors running trials in the state include University of Alabama at Birmingham, AstraZeneca, Pfizer. By stage, Alabama trials break down as Phase 1 (20), Phase 2 (43), Phase 3 (47), Phase 4 (8).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Alabama
Frequently Asked Questions — Clinical Trials in Alabama
How many clinical trials are currently recruiting in Alabama?
ClinicalMetric currently tracks 158 actively recruiting clinical trials with at least one location in Alabama. The total number of registered studies—including active but not currently enrolling trials—is 158. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Alabama?
Alabama hosts clinical trials across a broad range of medical conditions, including Obesity, Ovarian Cancer, Prostate Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Alabama serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Alabama?
To join a clinical trial in Alabama, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Alabama maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Alabama
NCT05723653 N/A
Recruiting
Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Int...
Condition
HIV Seropositivity
Enrollment
900 pts
Location
United States
Sponsor
University of Chicago
NCT07766005 Phase 2
Recruiting
A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (Th...
Condition
Hidradenitis Suppurativa (HS)
Enrollment
150 pts
Location
United States, Canada
Sponsor
Spyre Therapeutics, Inc.
NCT07231419 Phase 3
Recruiting
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With ...
Condition
Diabetic Peripheral Neuropathic Pain
Enrollment
734 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
NCT04629014 N/A
Recruiting
Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure
Condition
Pediatric Intestinal Failure
Enrollment
750 pts
Location
United States, Canada
Sponsor
Boston Children's Hospital
NCT02744677 N/A
Recruiting
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients...
Condition
Complex Congenital Heart Defect
Enrollment
108 pts
Location
United States
Sponsor
Edwards Lifesciences
NCT07175428 Phase 2
Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Antic...
Condition
Atrial Fibrillation (AF)
Enrollment
1,200 pts
Location
United States, Argentina, Brazil
Sponsor
Regeneron Pharmaceuticals
NCT07124000 N/A
Recruiting
DESTINY-PANTUMOUR04
Condition
Adenocarcinoma (NOS)
Enrollment
100 pts
Location
United States
Sponsor
AstraZeneca
NCT05135975 Phase 2
Recruiting
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurre...
Condition
Neuroblastoma
Enrollment
86 pts
Location
United States
Sponsor
Nationwide Children's Hospital
NCT07002034 Phase 2
Recruiting
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medic...
Condition
Adjustment Disorder
Enrollment
100 pts
Location
United States
Sponsor
Reunion Neuroscience Inc
NCT05564377 Phase 2
Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally A...
Condition
Advanced Malignant Solid Neoplasm
Enrollment
2,900 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT07818707 Phase 4
Recruiting
Post-Prandial Carbohydrate Metabolism in Individuals With and Without Post-Baria...
Condition
Hypoglycemia
Enrollment
40 pts
Location
United States
Sponsor
Joslin Diabetes Center
NCT07104656 N/A
Recruiting
Bony Overlap Following Use of the Inferior Border Saw for the 'Low and Short' Sa...
Condition
Mandibular Surgery
Enrollment
40 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT06087029 N/A
Recruiting
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
Condition
Type B Aortic Dissection
Enrollment
1,100 pts
Location
United States, Canada
Sponsor
Duke University
NCT03797495 N/A
Recruiting
Study of Individuals Affected With Hypoplasminogenemia
Condition
Plasminogen Deficiency
Enrollment
100 pts
Location
United States, Argentina, Australia
Sponsor
Indiana Hemophilia &Thrombosis
NCT02038166 N/A
Recruiting
Nasal Potential Difference (NPD) Protocol in Chronic Rhinosinusitis
Condition
Rhinosinusitis
Enrollment
20 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT06095505 Phase 2
Recruiting
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Condition
Small Cell Lung Cancer
Enrollment
120 pts
Location
United States
Sponsor
Puma Biotechnology, Inc.
NCT05218083 N/A
Recruiting
REmotely Monitored, Mobile Health Supported Multidomain Rehabilitation Program W...
Condition
COVID-19
Enrollment
120 pts
Location
United States
Sponsor
Duke University
NCT04752722 Phase 1, Phase 2
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incom...
Condition
Superficial Bladder Cancer
Enrollment
350 pts
Location
United States, Australia, Canada
Sponsor
enGene, Inc.
NCT06793891 N/A
Recruiting
Effects of Ashwagandha Extract on Stress Levels
Condition
Stress
Enrollment
60 pts
Location
United States
Sponsor
Nutraceuticals Research Instit
NCT04113382 Phase 1, Phase 2
Recruiting
Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy
Condition
Bowel Preparation
Enrollment
39 pts
Location
United States
Sponsor
Ferring Pharmaceuticals
NCT06742996 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib ...
Condition
Mantle Cell Lymphoma
Enrollment
300 pts
Location
United States, Argentina, Australia
Sponsor
BeOne Medicines
NCT05889624 N/A
Recruiting
Responding With Evidence and Access for Childhood Headaches
Condition
Headache
Enrollment
400 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
NCT06303505 Phase 1, Phase 2
Recruiting
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Pa...
Condition
Ovarian Cancer
Enrollment
334 pts
Location
United States, Belgium, Germany
Sponsor
Gilead Sciences
NCT07204275 Phase 2, Phase 3
Recruiting
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants...
Condition
Primary Membranous Nephropathy
Enrollment
176 pts
Location
United States, Australia, Brazil
Sponsor
Vertex Pharmaceuticals Incorpo
NCT05377372 N/A
Recruiting
Early Life Exposures Among Children With Sickle Cell Disease
Condition
Sickle Cell Disease
Enrollment
20 pts
Location
United States
Sponsor
University of Alabama at Birmi
Page 1 of 7 — 158 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology